Applied Therapeutics, Inc.
APLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $88,049 | $45,138 | $70,787 | $119,470 |
| - Cash | $11,945 | $30,421 | $50,762 | $79,398 |
| + Debt | $2,500 | $2,602 | $2,700 | $2,795 |
| Enterprise Value | $78,604 | $17,319 | $22,725 | $42,867 |
| Revenue | $1,000 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $1,000 | -$9,923 | -$7,837 | -$11,695 |
| % Margin | 100% | – | – | – |
| EBITDA | -$18,879 | -$23,098 | -$25,525 | -$33,022 |
| % Margin | -1,887.9% | – | – | – |
| Net Income | -$18,990 | -$21,330 | -$21,825 | $44,007 |
| % Margin | -1,899% | – | – | – |
| EPS Diluted | -0.13 | -0.15 | -0.15 | 0.32 |
| % Growth | 13.3% | 0% | -146.9% | – |
| Operating Cash Flow | -$18,401 | -$20,341 | -$28,636 | -$19,469 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$18,401 | -$20,341 | -$28,636 | -$19,469 |